The stock price’s performance over the year has been unpredictable, resulting in a mix of pessimistic and optimistic outlooks among investors. This year’s metric has recorded a Price decrease of -74.17%. However, over the past six months, we’ve seen a stronger performance of -64.69%. The
The performance of the stock price over the year has been up and down, leaving investors with either an optimistic or pessimistic outlook, depending on how they interpret the data. The index has shown a price loss of -75.07% this year. Over the last six
The stock price performance this year has been a mixed bag, which means people have different opinions about whether it’s been good or bad. Some may see it as optimistic, while others may view it as pessimistic. Until today this year the stock’s price performance
The 52-week high and low prices can offer valuable insights into a stock’s current standing and prospects for future performance. Theriva Biologics Inc’s current trading price is -93.89% away from its 52-week high, while its distance from the 52-week low is -21.56%. The stock’s price
All rights reserved © 2024, Powered By Smart TechOne